this case the most important stakeholders are the customers and the community. 2. I t would take about 12 years and 200 million dollars for research and development. This drug would benefit the people who are affected by river blindness. I believe many pharmaceutical in the area that river blindness occurs will invest in the cure for river blindness. 3. However‚ Merck could not justify such an investment in terms of financial at all‚ because this development is a big financial risk. Merck works
Premium Risk Investment Finance
Merck Ethics Study In developing a drug to combat river blindness‚ pharmaceutical company Merck discovered an opportunity to treat millions of affected peoples around the world that probably would never see commercial use. The drug in development‚ ivermectin‚ was unaffordable to the primary victims of river blindness‚ Third World peoples. Thus‚ Dr. Vagelos‚ the head of research at the time‚ treaded upon a ethical quagmire; he could either choose to scrap the drug and its further research or
Premium Ethics Philosophy of life Person
How many can you list? On what basis would you rank them in importance? The stakeholders in the Merk case is the people infected with river blindness‚ the community affected by river blindness‚ the employees of Merk‚ the company itself‚ and the Stockholders. In order of importance: 1. The infected people 2. The company 3. Stockholders 4. The employees 5. Community affected by river blindness What are the potential costs and benefits of such an investment? The Scientists were encouraging Merk
Premium Integrity Pharmaceutical drug Onchocerciasis
Introduction to the Case First established in 1668 in Darmstadt‚ Germany‚ Merck is currently (in 1978) one of the largest prescription drug producers in the world. After coming off a 10 year drug drought in the late 1970s‚ Merck put a large amount of money into research to continue its dominance in the prescription drug industry. The research-first approach worked and since then Merck has increased sales significantly. Merck’s mission was well stated by founder George W. Merck. “We try never to
Premium Pharmacology Onchocerciasis Pharmaceutical industry
Stake for Vagelos as CEO and for Merck as a company in deciding whether to invest in Dr. Campbell’s idea Although Dr. Campbell’s idea of a drug (Ivermectin) that could cure River blindness was a path-breaking opportunity for Merck‚ the company was faced with a number of ethical‚ financial and moral issues that forced its CEO to undergo deep thought and contemplation before investing in this idea. * Feasibility: There were concerns about the use of this drug on humans and the potential adverse
Premium Brand First-mover advantage Pharmacology
Merck was at the top of the pharmaceutical market for many years. The company made substantial profits almost every year. Not only were they a company that made money but they also made their financial gains in an ethical manor. Fourton magazine even named them the “most admired” company. But in 2004‚ the company would be faced with major challenges that would threaten to end the company’s existence. Their once best selling painkiller Viol had been recalled by the federal government because the drug
Premium Pharmacology Pharmaceutical industry
The actions Merck undertook when marketing Vioxx and emphasizing its safety even after finding out the product’s side effects endangered all its key stakeholders and showed the real face of the company that accented its highly ethical maxims. Cardiovascular side effects of the Vioxx increased the risk of complications that could have caused patient’s death‚ therefore Merck violated the basic right to life of all the Vioxx consumers. It was already mentioned that Vioxx caused 3468 deaths by heart
Premium Enron Business ethics Ethics
Merck & Co. Executive Summary Case Study Goal The goal of this case study is to examine the current operations of Merck & Co. Inc. and determine areas of potential concern‚ evaluate the effectiveness of the current business model‚ and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity‚ offer solutions‚ and make projections based upon historic data
Premium Financial ratio Financial ratios Strategic management
| Merck & Company Inc. | Case 1 | | | Introduction of the Company Merck was established in 1891 to improve human and animal health through the development of innovative products. Merck currently has two reportable segments‚ the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers‚ retailers‚ hospitals‚ clinics‚ government and managed health services providers. In the 1980’s the Merck was very
Premium Generic drug Pharmaceutical industry Mergers and acquisitions
decision (not covered in class?) Based on the pyramid of social responsibility‚ Merck is required to be profitable (base). Since the research of development will never be profitable to shareholders Merck should do develop the drug. Based on Merck’s actual value system‚ it wants to be ethical and even be a good corporate citizen. So Merck should conduct the research. Question 8 - If you were the senior executive of Merck‚ what would you do? (Open question) I would make assessment of the potential costs
Premium Social responsibility Corporation Business ethics